Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.00001
-
Shares outstanding
-
62,162,717
-
Total 13F shares
-
46,180,834
-
Share change
-
-1,808,029
-
Total reported value
-
$818,457,437
-
Put/Call ratio
-
75%
-
Price per share
-
$17.72
-
Number of holders
-
127
-
Value change
-
-$247,415,988
-
Number of buys
-
75
-
Number of sells
-
62
Institutional Holders of Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) as of Q3 2021
As of 30 Sep 2021,
Protagonist Therapeutics, Inc - Common Stock, par value $0.00001 (PTGX) was held by
127 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
46,180,834 shares.
The largest 10 holders included
FMR LLC, Point72 Asset Management, L.P., BVF INC/IL, BlackRock Inc., JOHNSON & JOHNSON, FARALLON CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, STATE STREET CORP, RTW INVESTMENTS, LP, and Artal Group S.A..
This page lists
127
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.